Your browser doesn't support javascript.
loading
Automated Speech Analysis in Bipolar Disorder: The CALIBER Study Protocol and Preliminary Results.
Anmella, Gerard; De Prisco, Michele; Joyce, Jeremiah B; Valenzuela-Pascual, Claudia; Mas-Musons, Ariadna; Oliva, Vincenzo; Fico, Giovanna; Chatzisofroniou, George; Mishra, Sanjeev; Al-Soleiti, Majd; Corponi, Filippo; Giménez-Palomo, Anna; Montejo, Laura; González-Campos, Meritxell; Popovic, Dina; Pacchiarotti, Isabella; Valentí, Marc; Cavero, Myriam; Colomer, Lluc; Grande, Iria; Benabarre, Antoni; Llach, Cristian-Daniel; Raduà, Joaquim; McInnis, Melvin; Hidalgo-Mazzei, Diego; Frye, Mark A; Murru, Andrea; Vieta, Eduard.
Afiliação
  • Anmella G; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • De Prisco M; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Joyce JB; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • Valenzuela-Pascual C; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Mas-Musons A; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • Oliva V; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Fico G; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • Chatzisofroniou G; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Mishra S; Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Al-Soleiti M; School of Graduate Medical Education, Mayo Clinic, Rochester, MN 55902, USA.
  • Corponi F; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • Giménez-Palomo A; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Montejo L; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • González-Campos M; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Popovic D; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • Pacchiarotti I; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Valentí M; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • Cavero M; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Colomer L; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • Grande I; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Benabarre A; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • Llach CD; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Raduà J; Department of Psychiatry and Psychology, Institute of Neuroscience, Hospital Clinic of Barcelona, 08036 Barcelona, Catalonia, Spain.
  • McInnis M; Bipolar and Depressive Disorders Unit, Digital Innovation Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Catalonia, Spain.
  • Hidalgo-Mazzei D; Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM), Instituto de Salud Carlos III, 28029 Madrid, Madrid, Spain.
  • Frye MA; Department of Medicine, School of Medicine and Health Sciences, Institute of Neurosciences (UBNeuro), University of Barcelona (UB), 08007 Barcelona, Catalonia, Spain.
  • Murru A; Office of Information Security, Mayo Clinic, Rochester, MN 55905, USA.
  • Vieta E; Alix School of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
J Clin Med ; 13(17)2024 Aug 23.
Article em En | MEDLINE | ID: mdl-39274208
ABSTRACT

Background:

Bipolar disorder (BD) involves significant mood and energy shifts reflected in speech patterns. Detecting these patterns is crucial for diagnosis and monitoring, currently assessed subjectively. Advances in natural language processing offer opportunities to objectively analyze them.

Aims:

To (i) correlate speech features with manic-depressive symptom severity in BD, (ii) develop predictive models for diagnostic and treatment outcomes, and (iii) determine the most relevant speech features and tasks for these analyses.

Methods:

This naturalistic, observational study involved longitudinal audio recordings of BD patients at euthymia, during acute manic/depressive phases, and after-response. Patients participated in clinical evaluations, cognitive tasks, standard text readings, and storytelling. After automatic diarization and transcription, speech features, including acoustics, content, formal aspects, and emotionality, will be extracted. Statistical analyses will (i) correlate speech features with clinical scales, (ii) use lasso logistic regression to develop predictive models, and (iii) identify relevant speech features.

Results:

Audio recordings from 76 patients (24 manic, 21 depressed, 31 euthymic) were collected. The mean age was 46.0 ± 14.4 years, with 63.2% female. The mean YMRS score for manic patients was 22.9 ± 7.1, reducing to 5.3 ± 5.3 post-response. Depressed patients had a mean HDRS-17 score of 17.1 ± 4.4, decreasing to 3.3 ± 2.8 post-response. Euthymic patients had mean YMRS and HDRS-17 scores of 0.97 ± 1.4 and 3.9 ± 2.9, respectively. Following data pre-processing, including noise reduction and feature extraction, comprehensive statistical analyses will be conducted to explore correlations and develop predictive models.

Conclusions:

Automated speech analysis in BD could provide objective markers for psychopathological alterations, improving diagnosis, monitoring, and response prediction. This technology could identify subtle alterations, signaling early signs of relapse. Establishing standardized protocols is crucial for creating a global speech cohort, fostering collaboration, and advancing BD understanding.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça